aMT 25mg Pellets

PRODUCT DESCRIPTION

Introduction

Alpha-Methyltryptamine (aMT) 25mg pellets are a precise dosage form of a synthetic psychedelic and stimulant compound belonging to the substituted tryptamine class. aMT exhibits psychoactive effects primarily through serotonin receptor agonism, alongside stimulant properties due to monoamine release. The pellet form allows controlled and consistent dosing, suitable for laboratory research and pharmacological investigations of psychedelic substances.

Chemical Properties and Specifications

2.1 Structural and Molecular Characteristics

• Chemical Formula: C11H14N2

• Molecular Weight: 174.24 g/mol

• CAS Number: 7795-52-0

• IUPAC Name: 1-(1H-indol-3-yl)propan-2-amine

• Synonyms:

  • aMT

  • Alpha-Methyltryptamine

  • Indopan (historical medical use)

2.2 Physical Properties and Purity Standards

• Appearance: White to off-white fine crystalline pellets

• Purity: ≥98% purity standard for research-grade material

• Solubility: Poorly soluble in water, soluble in organic solvents such as ethanol and DMSO

• Storage Recommendations: Store in a cool, dry, dark place at -20°C in airtight containers to maintain chemical integrity

Pharmacological Profile and Mechanism of Action

3.1 Proposed Mechanism of Action

aMT acts as a releasing agent and reuptake inhibitor of serotonin, dopamine, and norepinephrine, as well as a non-selective serotonin receptor agonist. This combined activity produces psychedelic, stimulant, and entactogenic effects. The alpha-methyl substitution prolongs duration and enhances oral bioavailability compared to other tryptamines.

3.2 Research Applications

The 25mg pellet formulation facilitates accurate administration in research studying psychedelic receptor mechanisms, behavioral effects, and pharmacokinetics. aMT pellets are used in vitro and in vivo to explore monoaminergic neurotransmission and potential antidepressant effects.

Comparative Analysis with Related Compounds

4.1 Compare the compound to Compound(s) often compared to

aMT is structurally analogous to α-ethyltryptamine (αET), N,N-dimethyltryptamine (DMT), and 5-MeO-DMT. Its longer duration and oral activity differentiate it from DMT, which has a shorter effect span. Compared to synthetic stimulants, aMT presents a unique dual psychedelic and stimulant profile.

4.2 Advantages for Research

The pellet form offers precise dosing and ease of handling, improving experimental consistency. aMT’s combination of serotonergic and stimulant actions provides comprehensive models for neuropharmacological studies.

Safety and Handling Guidelines

5.1 Laboratory Safety

Use gloves, eye protection, and work in well-ventilated spaces or fume hoods when handling pellets. Avoid inhalation and skin contact.

5.2 Disposal and Environmental Considerations

Dispose of waste according to regulated hazardous chemical protocols to protect the environment.

5.3 Regulatory Status

aMT is regulated in several countries. Confirm local regulations before procurement or use.

Frequently Asked Questions (FAQs)

1. What is the dosage strength of aMT pellets?
   Each pellet contains 25 mg of alpha-methyltryptamine.

2. What effects does aMT produce?
   Psychedelic, stimulant, and entactogenic effects through monoamine release and serotonin receptor agonism.

3. How long do the effects last?
   Typically 8 to 12 hours or longer depending on dose and individual factors.

4. Is aMT orally active?
   Yes, due to alpha-methylation enhancing bioavailability.

5. Is aMT a controlled substance?
   Yes, it is regulated in many countries due to psychoactive properties.

Conclusion

aMT 25mg pellets provide a standardized, research-grade formulation of a synthetic psychedelic and stimulant compound. Their purity, dosage precision, and prolonged pharmacological profile make them a valuable tool in neurochemical, behavioral, and pharmacokinetic research, with necessary safety and regulatory adherence.